Qiagen N.V. (QGEN)
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
Rapid7 Announces Second Quarter 2026 Financial Results
Playboy Reports Second Quarter 2026 Financial Results
Nasdaq Announces the Board of Directors of its U.S. Exchanges
P3 Health Partners Announces Second Quarter 2026 Results
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
Netcapital Inc. Granted Additional 180-Day Nasdaq Compliance Period for Minimum Bid Price Requirement
Rackspace Technology Reports Second Quarter 2026 Results
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
Quantum Reports Fiscal First Quarter 2027 Financial Results